Skip to content

Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis

The Chronic Effects of Low-Load Blood Flow Restriction or Standard of Care Resistance Exercise on Muscle and Neuromuscular Function in Patients With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05177952
Enrollment
20
Registered
2022-01-05
Start date
2022-01-01
Completion date
2024-05-31
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Flow Restriction, Multiple Sclerosis, Training Study

Keywords

Blood Flow Restriction, Multiple Sclerosis, Exercise

Brief summary

This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.

Detailed description

The purpose of this study is to compare the effectiveness of the current Multiple Sclerosis standard of care exercise recommendations to low-load resistance training with blood flow restriction on functional outcomes, strength, muscle size, and neuromuscular control in Multiple Sclerosis patients. This study involves completing 2 training sessions per week for 12 weeks as well as pre- and post-training assessment visits for a total of 29 visits over 14 weeks. All visits will be on UCF's campus with a member of the research team.

Interventions

OTHERBlood Flow Restriction

Resistance training with BFR

OTHERStandard of Care

Resistance Training with no BFR

Sponsors

AdventHealth
CollaboratorOTHER
University of Central Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Participants and Investigators will be aware of treatment groups

Intervention model description

Randomized between group parallel

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Females between the ages of 18 to 55 * Diagnosed with Multiple Sclerosis * Expanded Disability Status Score of 0 to 6.5 * Able to walk 10 meters without assistance * Are willing to come in for all 29 testing visits over 14 weeks

Exclusion criteria

* No other known cardiovascular, pulmonary, metabolic, muscular, and/or coronary heart disease * Multiple Sclerosis relapse in the past 30 days * Are not currently undergoing a rehabilitation protocol * Are not currently seeking medical care for a chronic condition that could limit exercise capacity other than multiple sclerosis * Are not currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
Change in Functional Outcomes- 10meterDay 2, Week 4 and 8, Day 28determined via changes in 10 meter walk test, measured by how fast (in minutes and seconds) someone can walk 10 meters
Change in Functional Outcomes- 6min walkDay 2, Week 4 and 8, Day 28determined via changes in 6 minute walk test, measured by how far (in feet) someone can walk in 6 minutes
Change in Functional Outcomes- CSTDay 2, Week 4 and 8, Day 28determined via changes in sit-to-stand test, measured by how quickly someone can stand from a seated position
Change in Functional Outcomes- 30CSTDay 2, Week 4 and 8, Day 28determined via changes in 30 second sit-to-stand, measured by how many times someone can stand from a seated position in 30 seconds
Change in Functional Outcomes- MFISDay 2, Week 4 and 8, Day 28determined via changes in Modified Fatigue Impact Scale Questionnaire, sum score of answers on the questionnaire

Secondary

MeasureTime frameDescription
Changes in StrengthDay 3, Week 4 and 8, Day 29determined via maximal voluntary contractions on the Biodex

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026